Skin Conditioning Extract & Liposome
[INQ. NO. 2308C34] Manufactured in GMP facilities, STeMiN®, known as “Human Adipocyte Conditioned Media Extract,” is a cosmetic ingredient registered under the INCI Name. Proven to have cosmetic performance, it boasts secured patents for whitening, tissue regeneration, wrinkle improvement, and immune response suppression.
STeMiN® has completed various evaluations for toxicity and safety, including skin irritation tests, according to KFDA guidelines. After thorough skin clinical trials at accredited institutions, data confirming its whitening, skin-soothing, and wrinkle-improving effects have been obtained, making STeMiN® a safe and effective cosmetic ingredient.
Furthermore, a liposome product known as STeMiN®-Liposome has been developed. It contains 10% or 20% of the STeMiN® extract that has undergone liposome encapsulation. Liposomes are recognized as a drug delivery system (DDS) developed to effectively deliver active substances into cells.
Made up of a double-layered membrane of phospholipids, these capsules allow the active ingredients to pass through the interstices of the stratum corneum skin cells and effectively reach the dermis. As a product that enhances the stability of the raw material, it can be distributed at room temperature with preservation treatment.
The brains behind these remarkable products is CEFObio Co., Ltd., established in 2011 with the aim of research, development, and commercialization of stem cell therapeutics. Based on various original technologies related to stem cells, the company is vigorously developing cell therapeutics, successfully conducting Phase-1 clinical trials of stem cell therapeutics produced in its own GMP.
The STeMiN® brand is the culmination of years of stem cell research, and in 2022, it was selected as a “Next Generation World-Class Product” by KOTRA, and is currently being exported to South Africa and India.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods